Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0S0GM
|
|||
Former ID |
DIB006484
|
|||
Drug Name |
ADX-10061
|
|||
Synonyms |
CEE-310; NNC-687; NO-687; CEE-03-310; NNC-01-0687; NNC-01-687
Click to Show/Hide
|
|||
Indication | Psychotic disorder [ICD-11: 6A20-6A25] | Discontinued in Phase 2 | [1] | |
Company |
Addex Pharmaceuticals; Novo Nordisk A/S
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dopamine D1 receptor (D1R) | Target Info | Antagonist | [2] |
KEGG Pathway | Calcium signaling pathway | |||
cAMP signaling pathway | ||||
Neuroactive ligand-receptor interaction | ||||
Gap junction | ||||
Dopaminergic synapse | ||||
Parkinson's disease | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Morphine addiction | ||||
Alcoholism | ||||
Panther Pathway | Dopamine receptor mediated signaling pathway | |||
Pathwhiz Pathway | Dopamine Activation of Neurological Reward System | |||
Reactome | Dopamine receptors | |||
G alpha (s) signalling events | ||||
WikiPathways | Hypothetical Network for Drug Addiction | |||
Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | ||||
Genes and (Common) Pathways Underlying Drug Addiction | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001476) | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001476) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.